Table 2 The detailed information on the therapeutic protocol used in patients
Total | Anaplastic Oligo, IDH-mutant, 1p/19q codeletion | Anaplastic Astro, IDH-mutant | Anaplastic Astro, IDH-wildtype | Glioblastoma, IDH-mutant | Glioblastoma, IDH-wildtype | Anaplastic Astro, NOSa | Glioblastoma, NOSa | ||
|---|---|---|---|---|---|---|---|---|---|
TMZb cycles | 200 | 8 (4%) | 34 (17%) | 30 (15%) | 28 (14%) | 84 (42%) | 9 (5%) | 7 (4%) | |
RT + TMZc→TMZ cycles | 3–5 | 36 (18%) | 1 | 6 | 4 | 7 | 14 | 3 | 1 |
6 | 154 (77%) | 6 | 25 | 25 | 21 | 66 | 5 | 6 | |
7–12 | 7 (4%) | – | 3 | – | – | 4 | – | – | |
Only TMZ | 3–5 | 2 (1%) | – | – | 1 | – | – | 1 | – |
6 | 1 (1%) | 1 | – | – | – | – | – | – | |
7–12 | – | – | – | – | – | – | – | – |
